Soujanya Life Sciences DMF, CEP, Written Confirmations, FDF, Prices, Patents, Patents & Exclusivities, Dossier, Manufacturer, Licensing, Distributer, Suppliers, News, GMP

Soujanya Group announces state-of-the-art R&D Center for its new Lifesciences

02 Oct 2023

// THE PRINT

Soujanya Group announces Research & Development Center at Navi Mumbai facility

01 Aug 2023

// CNBCTV

Soujanya Color Director Views Growth In Indian chemical industry

07 Jul 2022

// INDIANCHEMICAL

DATA COMPILATION
#PharmaFlow

Contact Supplier

Website

BioAsia

Not Confirmed

Book a meeting

envelop Contact Supplier

DIGITAL CONTENT

1 CORPORATE CONTENT #SupplierSpotlight, 3 NEWS #PharmaBuzz

media
1 CORPORATE CONTENT #SupplierSpotlight
3 NEWS #PharmaBuzz

ACTIVE PHARMA INGREDIENTS

7 All APIs, 7 Listed APIs

7 All APIs
7 Listed APIs

INTERMEDIATES

16 All Intermediates

16 All Intermediates

KEY PRODUCTS

(R)-3-(4-(5-bromo-2-chlorobenzyl)phenoxy)tetrahydrofuran, 2,3,4,6-tetrakis-o-trimethylsilyl-d-gluconolactone, 2-Chlorobenzonitrile, 4-bromo-1-chloro-2-(4-ethoxybenzyl)benzene, 4-Bromomethyl-2-cyanobiphenyl, 4-Oxo-1,4-dihydroquinoline-3-carboxylic acid, Caprylic Capric Triglyceride, Dapagliflozin, Dapagliflozin Propanediol Monohydrate, Dibenzimidazole, Empagliflozin, Isopropyl Myristate API, Isopropyl Palmitate, Teneligliptin Hydrobromide

(R)-3-(4-(5-bromo-2-chlorobenzyl)phenoxy)tetrahydrofuran
2,3,4,6-tetrakis-o-trimethylsilyl-d-gluconolactone
2-Chlorobenzonitrile
4-bromo-1-chloro-2-(4-ethoxybenzyl)benzene
4-Bromomethyl-2-cyanobiphenyl
4-Oxo-1,4-dihydroquinoline-3-carboxylic acid
Caprylic Capric Triglyceride
Dapagliflozin
Dapagliflozin Propanediol Monohydrate
Dibenzimidazole
Empagliflozin
Isopropyl Myristate API
Isopropyl Palmitate
Teneligliptin Hydrobromide

Soujanya Life Sciences makes API & intermediates for various therapeutic categories including Antidiabetic, Anti-Hypertensive, etc.

About

Soujanya Life Sciences is a new division of the Soujanya Group, a 40-year-old organization with a strong presence in 50 countries and expertise in pigments and dyes. Soujanya Life Sciences combines the energy and optimism of a new venture with the proven credibility of the parent group. It manufactures sustainable and efficient APIs and advanced intermediates for various therapeutic categories, including antidiabetics, anti-hypertensives, antioxidants, anti-aging, vitamins, nutraceuticals, etc. The company has a R&D lab in Pune. It currently operates two state-of-the-art LL production sites and plans to set up additional sites in the future.